MRI Markers for Early Assessment of Bladder Cancer: A Review
暂无分享,去创建一个
Ayman El-Baz | Mohammed Ghazal | Mohammed Elmogy | Adel Said Elmaghraby | Fahmi Khalifa | Ahmed Haddad | Kamal Hammouda | Hanan E. Darwish | A. El-Baz | F. Khalifa | Mohammed M Elmogy | M. Ghazal | A. Haddad | K. Hammouda | H. Darwish
[1] M. Lai,et al. Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells. , 2001, The Journal of urology.
[2] Jeon-Hor Chen,et al. Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer , 2015, Translational oncology.
[3] Yan Guo,et al. Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection , 2014, Abdominal Imaging.
[4] Jurgen J Fütterer,et al. Multiparametric MRI of the bladder: ready for clinical routine? , 2014, AJR. American journal of roentgenology.
[5] P. Carroll,et al. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. , 1994, Radiology.
[6] Zhongqiu Wang,et al. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. , 2014, European journal of radiology.
[7] Henry Rusinek,et al. Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness , 2015, Abdominal Imaging.
[8] J O Barentsz,et al. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer. , 2006, European urology.
[9] Maria Triantafyllou,et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. , 2013, European urology.
[10] Tarek El-Diasty,et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging , 2009, European Radiology.
[11] Bo Du,et al. Shape prior constrained PSO model for bladder wall MRI segmentation , 2017, Neurocomputing.
[12] M. Bulut,et al. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. , 2011, The British journal of radiology.
[13] Sadhna Verma,et al. Urinary bladder cancer: role of MR imaging. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[14] Jian Guan,et al. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. , 2015, AJR. American journal of roentgenology.
[15] J. Stockman,et al. Association Between Smoking and Risk of Bladder Cancer Among Men and Women , 2013 .
[16] Zhengrong Liang,et al. An Adaptive Window-Setting Scheme for Segmentation of Bladder Tumor Surface via MR Cystography , 2012, IEEE Transactions on Information Technology in Biomedicine.
[17] Hongbing Lu,et al. Detection of the Invasion of Bladder Tumor into Adjacent Wall Based on Textural Features Extracted from MRI Images , 2010, Virtual Colonoscopy and Abdominal Imaging.
[18] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[19] R Y Ball,et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .
[20] Naoya Masumori,et al. Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer , 2018, Oncotarget.
[21] Tarek El-Diasty,et al. Diffusion‐weighted magnetic resonance imaging in follow‐up of superficial urinary bladder carcinoma after transurethral resection: initial experience , 2012, BJU international.
[22] Valeria Panebianco,et al. Improving Staging in Bladder Cancer: The Increasing Role of Multiparametric Magnetic Resonance Imaging. , 2016, European urology focus.
[23] João Manuel R. S. Tavares,et al. Novel Approach to Segment the Inner and Outer Boundaries of the Bladder Wall in T2-Weighted Magnetic Resonance Images , 2011, Annals of Biomedical Engineering.
[24] Kazutaka Saito,et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness , 2011, European Radiology.
[25] Fatma Taher,et al. Computer-Aided Diagnostic System for Early Detection of Acute Renal Transplant Rejection Using Diffusion-Weighted MRI , 2019, IEEE Transactions on Biomedical Engineering.
[26] A Rajesh,et al. Bladder cancer: evaluation of staging accuracy using dynamic MRI. , 2011, Clinical radiology.
[27] M. Fouda,et al. Gene expression of excision repair cross-complementation group 1 enzyme as a novel predictive marker in patients receiving platinum-based chemotherapy in advanced bladder cancer , 2018 .
[28] Erlend Hodneland,et al. In vivo estimation of glomerular filtration in the kidney using DCE-MRI , 2011, 2011 7th International Symposium on Image and Signal Processing and Analysis (ISPA).
[29] Zhengrong Liang,et al. Characterization of texture features of bladder carcinoma and the bladder wall on MRI: initial experience. , 2013, Academic radiology.
[30] N. Cowan,et al. Understanding multislice CT urography techniques: many roads lead to Rome , 2006, European Radiology.
[31] Dieter Jocham,et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. , 2013, European urology.
[32] J. Witjes,et al. MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER , 2016 .
[33] 舩津 宏之,et al. Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection , 2013 .
[34] Wei Zeng,et al. Computer-aided detection of bladder tumors based on the thickness mapping of bladder wall in MR images , 2010, Medical Imaging.
[35] A D MacVicar,et al. Bladder cancer staging , 2000, BJU international.
[36] Xuelong Li,et al. Adaptive Shape Prior Constrained Level Sets for Bladder MR Image Segmentation , 2014, IEEE Journal of Biomedical and Health Informatics.
[37] Shahrokh F. Shariat,et al. An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer , 2016, Biomolecules.
[38] Yuta Shibamoto,et al. MR imaging of urinary bladder cancer for T‐staging: A review and a pictorial essay of diffusion‐weighted imaging , 2013, Journal of magnetic resonance imaging : JMRI.
[39] S. Groshen,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Hongbing Lu,et al. Partial sparse shape constrained sector-driven bladder wall segmentation , 2015, Machine Vision and Applications.
[41] Adilson Prando,et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade , 2009 .
[42] Maximilian Burger,et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.
[43] L. Sobin,et al. Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.
[44] Xi Zhang,et al. 3D detection and extraction of bladder tumors via MR virtual cystoscopy , 2015, International Journal of Computer Assisted Radiology and Surgery.
[45] A. Tanimoto,et al. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. , 1992, Radiology.
[46] Soroush Rais-Bahrami,et al. Contemporary role of advanced imaging for bladder cancer staging. , 2016, Urologic oncology.
[47] H J JEWETT,et al. Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases. , 1946, The Journal of urology.
[48] Antonio Alcaraz,et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. , 2005, The Journal of urology.
[49] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[50] S. Daneshmand,et al. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. , 2012, Urology.
[51] Paul Sargos,et al. Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma. , 2015, European journal of radiology.
[52] Yair Lotan,et al. Treatment of Non‐Metastatic Muscle‐Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline , 2017, The Journal of urology.
[53] Maria Triantafyllou,et al. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. , 2013, European journal of cancer.
[54] Yu Fan,et al. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. , 2013, Academic radiology.
[55] P. Rigatti,et al. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. , 1996, The Journal of urology.
[56] A. El-Baz,et al. Towards non-invasive diagnostic techniques for early detection of acute renal transplant rejection: A review , 2017 .